Measuring soluble platelet glycoprotein VI in human plasma by ELISA
- 1 January 2009
- journal article
- research article
- Published by Informa UK Limited in Platelets
- Vol. 20 (3), 143-149
- https://doi.org/10.1080/09537100802710286
Abstract
Recent experimental evidence demonstrates that the platelet-specific collagen receptor, glycoprotein (GP)VI is essentially all uncleaved on normal circulating platelets, but is shed from the platelet surface in a metalloproteinase-dependent manner in response to GPVI ligands (including collagen), anti-GPVI antibodies or activation at the platelet Fc receptor, FcγRIIa. This raises the question of whether shed ectodomain fragment in plasma could be a useful biomarker of thrombotic risk and/or autoimmune thrombocytopenia. In this study, we developed a sandwich enzyme-linked immunosorbent assay (ELISA) for measuring soluble GPVI in human plasma, using rabbit anti-GPVI polyclonal antibody in the solid-phase, murine anti-GPVI monoclonal antibody (1A12) in the fluid-phase and horseradish peroxidase (HRP)-coupled anti-mouse antibody and enhanced chemiluminescence (ECL) for detection. The ELISA was optimized for sensitivity, reproducibility, inter- and intra-assay precision, addition and recovery and detected GPVI in plasma with a lower detection limit of ∼1 ng/mL. Effects of different anti-coagulants (trisodium citrate, acid-citrate-dextrose or EDTA) were negligible. In ten healthy donors, soluble plasma GPVI levels were 18.9 ± 4.1 ng/mL. Treating normal platelet-rich plasma with a GPVI ligand (collagen-related peptide, CRP), calmodulin inhibitor W7 (that induces GPVI shedding without platelet activation) or N-ethylmaleimide (that directly activates platelet sheddases), under conditions previously shown to induce GPVI shedding, also increased plasma GPVI levels by up to ∼7-fold, compared to previously reported autoimmune (anti-GPVI) patient plasma where soluble GPVI was ∼10-fold higher than normal. Characterization of this sensitive ELISA should facilitate analysis of functional/diagnostic role(s) for soluble GPVI in human plasma associated with thrombotic/immune dysfunction.Keywords
This publication has 33 references indexed in Scilit:
- Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcγRIIa and induce GPVI ectodomain sheddingPlatelets, 2009
- Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcγRIIaBlood, 2008
- Controlled shedding of platelet glycoprotein (GP)VI and GPIb–IX–V by ADAM family metalloproteinasesJournal of Thrombosis and Haemostasis, 2007
- Laminin stimulates spreading of platelets through integrin α6β1–dependent activation of GPVIBlood, 2006
- Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagenBlood, 2005
- Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinaseBlood, 2004
- Platelet-collagen interaction: is GPVI the central receptor?Blood, 2003
- The Fc receptor γ‐chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C‐type lectin, convulxinEuropean Journal of Biochemistry, 2002
- A Novel Viper Venom Metalloproteinase, Alborhagin, Is an Agonist at the Platelet Collagen Receptor GPVIJournal of Biological Chemistry, 2001
- Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VIBiochemical Journal, 1999